Outcomes of Secondary Endovascular Aortic Repair After Initial Frozen Elephant Trunk Procedure
1 other identifier
observational
30
0 countries
N/A
Brief Summary
Objective Complex aortic pathology has been revolutionized with the use of hybrid prostheses such as the Thoraflex® Hybrid Frozen Elephant Trunk (FET). The aim of this study was to evaluate the midterm results of secondary extension of the FET by thoracic endovascular aortic repair (TEVAR). Few data are present in the literature regarding the outcomes of this secondary treatment. The investigators perform a prospective study between 2015 and 2022 in a tertiary aortic center on all consecutive patients having undergone TEVAR after FET implantation. The TEVAR endograft covered most of the 10 cm FET module with 2 to 4 mm oversizing. All patients were monitored by computerized angiography (CTA) at 6-month and yearly thereafter. The aim of this study was the feasibility of theses secondary connexion and the mid term outcomes of the endovascular treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 24, 2022
CompletedFirst Posted
Study publicly available on registry
October 7, 2022
CompletedOctober 7, 2022
October 1, 2022
5 years
May 24, 2022
October 5, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Absence of endoleak after secondary connexion
Absence of Type 1A endoleak
yearly thereafter up to 5 years
Secondary Outcomes (2)
Feasibility of the secondary connexion
During the surgery
Absence of endoleak after secondary connexion
early thereafter up to 5 years
Interventions
Under general anesthesia, via percutaneous femoral access, the investigators implant a TEVAR in the endovascular part of a FET. This secondary connexion is indicated in case distal thoracic aortic involvement such as aneurysm or dissection.
Eligibility Criteria
Patient with aortic cross replacement by FET who are indicated for a secondary connexion in emergency : Aortic type A dissection with organ malperfusion Defect in the expansion of the FET module or in chronical evolution: Type 1 and Type 2 Thoracoabdominal aneurysm (TAAA) with a diameter at \> 6 cm Aneurysmal evolution of the false lumen of a dissected aorta.
You may qualify if:
- Patient with aortic cross replacement by FET and
- Type 1 and Type 2 Thoracoabdominal aneurysm (TAAA) with a diameter at \> 6 cm or
- an aortic dissection, Type A (TAAD) or Type B (TBAD) with either organ malperfusion due to compression of the true channel or aneurysmal evolution of the dissected aorta, or
- A defect in the expansion of the FET module
You may not qualify if:
- No aortic cross replacement by FET
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Paul Sabatier of Toulouselead
- Jean Porterie, MDcollaborator
- Thibaut Boisroux, MDcollaborator
- Bertrand Marcheix, MD, PhDcollaborator
- Jean Baptiste Ricco, MD, PhDcollaborator
- Xavier Chaufour, MD, PhDcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Hostalrich Aurelien, MD
Study Record Dates
First Submitted
May 24, 2022
First Posted
October 7, 2022
Study Start
January 1, 2015
Primary Completion
January 1, 2020
Study Completion
January 1, 2022
Last Updated
October 7, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share
Data are anonymised in our local prospective database shared between all investigators.